Connors Investor Services Inc. Sells 1,378 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Connors Investor Services Inc. lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 34,651 shares of the company’s stock after selling 1,378 shares during the period. Connors Investor Services Inc.’s holdings in Prestige Consumer Healthcare were worth $2,386,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Congress Asset Management Co. MA increased its holdings in Prestige Consumer Healthcare by 596.2% during the 4th quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after purchasing an additional 581,685 shares during the period. Norges Bank purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at $27,739,000. Allspring Global Investments Holdings LLC raised its holdings in shares of Prestige Consumer Healthcare by 26.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after acquiring an additional 272,773 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Prestige Consumer Healthcare by 9.0% in the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after acquiring an additional 171,357 shares in the last quarter. Finally, F M Investments LLC purchased a new stake in Prestige Consumer Healthcare in the second quarter worth about $11,162,000. Institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $80.00 target price on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. DA Davidson lifted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Finally, StockNews.com lowered Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.75.

Prestige Consumer Healthcare Trading Down 0.6 %

Prestige Consumer Healthcare stock opened at $73.68 on Tuesday. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.80. The stock has a market cap of $3.65 billion, a PE ratio of 17.67, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The stock has a 50-day moving average of $70.88 and a two-hundred day moving average of $69.58.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s revenue for the quarter was down 4.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.06 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.